ARTICLE | Product Development
NIH-led ACTIV partnership close to selecting repurposed therapies for COVID-19 trials
May 19, 2020 10:07 PM UTC
The Accelerating COVID-19 Therapeutic Interventions and Vaccines public-private partnership is close to selecting a handful of therapies to test in one or more large-scale master protocols, NIH Director Francis Collins said Tuesday.
Collins also expressed optimism about the potential effectiveness of mAbs and said trial results could be available this summer. ...